The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

NAActive, not recruitingINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

May 27, 2015

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Breast Neoplasms
Interventions
OTHER

endocrine therapy alone without radiotherapy

Patients will not receive radiotherapy, which is the current standard for treatment for their type of breast cancer.

Trial Locations (13)

10065

Memorial Sloan Kettering Cancer Center, New York

11042

Northwell Health, Lake Success

19104

University of Pennsylvania, Philadelphia

27853

East Carolina University, Greenville

48109

University of Michigan, Ann Arbor

53226

Medical College of Wisconsin, Milwaukee

60153

Loyola University Medical Center, Maywood

75390

University of Texas Southwestern Medical Center, Dallas

94305

Stanford University, Stanford

06520

Yale University, New Haven

Unknown

Johns Hopkins University, Baltimore

02138

Harvard University, Cambridge

08901

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

Rutgers Cancer Institute of New Jersey

OTHER

collaborator

East Carolina University

OTHER

collaborator

Stanford University

OTHER

collaborator

Harvard University

OTHER

collaborator

Yale University

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

Medical College of Wisconsin

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Loyola University

OTHER

lead

University of Michigan Rogel Cancer Center

OTHER

NCT02400190 - The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) | Biotech Hunter | Biotech Hunter